The Latest in Multiple Sclerosis

Early Interferon Treatment Delays Time to Clinically Definite MS

March 6, 2017

Multiple Sclerosis

David Hafler, MD

March 6, 2017

Multiple Sclerosis

How to Treat Pediatric MS

March 6, 2017

Switch From Fingolimod to Alemtuzumab Might Trigger MS Relapse

March 3, 2017

Multiple Sclerosis

Relatives of Patients With MS Show Early Signs of Disease

March 3, 2017

Multiple Sclerosis

Ocrelizumab Reduces Disease Progression in MS

January 30, 2017

Multiple Sclerosis

Treatment Reduces Risk of Long-Term Disability in MS

January 27, 2017

Multiple Sclerosis

Rituximab May Have Advantages Over Fingolimod and Natalizumab in MS

December 28, 2016

Multiple Sclerosis

What Are the Best Treatments for Bladder Dysfunction in MS?

December 27, 2016

Multiple Sclerosis

Which Factors Predict Relapse Freedom After Cessation of MS Treatment?

November 28, 2016

Multiple Sclerosis

What Do We Know About Pediatric MS?

November 28, 2016

Higher Latitude Is Associated With Earlier Age of MS Onset

November 28, 2016

Multiple Sclerosis

Opicinumab May Benefit Patients With Relapsing-Remitting MS

November 23, 2016

Multiple Sclerosis

Alemtuzumab Reduces Preexisting MS Disability

November 1, 2016

Multiple Sclerosis

Vitamin D as an Add-On Therapy May Improve MRI Outcomes in MS

November 1, 2016

Multiple Sclerosis